Radiant Innovation

Radiant Innovation FCF per Share

The Free Cash Flow per Share of Radiant Innovation (3373.TWO) as of Nov 20, 2026 is -0.12 TWD. In the previous year, Free Cash Flow per Share was 0.16 TWD — a change of -175.02% (lower).

FCF per Share

-0.12TWD

YoY

-175.02%

Last updated:

Free Cash Flow per Share of Radiant Innovation is 2025 -0.12 TWD. Free Cash Flow per Share of Radiant Innovation was 2024 0.16 TWD. It decreases by -175.02% lower compared to the previous year.

The Radiant Innovation FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
0.09 TWD
Jan 1, 2019
1.46 TWD
Jan 1, 2020
17.27 TWD
Jan 1, 2021
-3.52 TWD
Jan 1, 2022
-1.02 TWD
Jan 1, 2023
-0.11 TWD
Jan 1, 2024
0.16 TWD
Jan 1, 2025
-0.12 TWD
The Radiant Innovation FCF per Share history
YEARFCF per ShareYoY
-0.12TWD-175.02%
0.16TWD-243.31%
-0.11TWD-88.96%
-1.02TWD-70.97%
-3.52TWD-120.36%
17.27TWD+1,079.47%
1.46TWD+1,577.79%
0.09TWD-109.84%
-0.89TWD-169.51%
1.28TWD-199.81%
-1.28TWD+81.52%
-0.70TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

Free Cash Flow per Share of Radiant Innovation is -0.12 TWD in 2025.

Free Cash Flow per Share of Radiant Innovation changed from 0.16 TWD to -0.12 TWD, representing a -175.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Radiant Innovation

All Key Metrics — Radiant Innovation